Physician

Carol H Cooper, M.D.

According to 2025 Medicare claims, Carol Cooper, M.D. (NPI: 1154346369) practices dermatology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Boyd, KY. This provider's primary affiliated billing organization is KING'S DAUGHTERS MEDICAL SPECIALTIES, INC. (NPI: 1265063580; TIN: 264183569) and primary practice location at 41101-7575.

Cooper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 724 traditional Medicare patients, billed 3,242 HCPCS/CPT codes, and received $98,131 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,224 prescription claims across 563 beneficiaries totaling $1,037,748 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 28 records totaling $730. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $177,897 to $98,131. In contrast, Part D prescription costs have moved sharply higher in recent years, from $322,221 to $1,037,748. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$89K$178K2015 Medicare payment: $177,897 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $165,882 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $146,001 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $158,426 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $161,585 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,288 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $107,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $102,979 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $102,276 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $98,131 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2924,836$177,897
20161,2834,915$165,882
20171,1374,427$146,001
20181,2374,684$158,426
20191,2295,203$161,585
20201,0783,633$92,288
20211,1143,990$107,444
20229123,543$102,979
20238413,464$102,276
20247243,242$98,131

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$519K$1.0M2015 Drug cost: $322,221 (USD; Tot_Drug_Cst)2016 Drug cost: $386,513 (USD; Tot_Drug_Cst)2017 Drug cost: $278,011 (USD; Tot_Drug_Cst)2018 Drug cost: $365,106 (USD; Tot_Drug_Cst)2019 Drug cost: $378,069 (USD; Tot_Drug_Cst)2020 Drug cost: $602,501 (USD; Tot_Drug_Cst)2021 Drug cost: $674,292 (USD; Tot_Drug_Cst)2022 Drug cost: $516,739 (USD; Tot_Drug_Cst)2023 Drug cost: $965,548 (USD; Tot_Drug_Cst)2024 Drug cost: $1,037,748 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015475966$322,221
20165211,092$386,513
20175421,073$278,011
20186601,276$365,106
20196251,360$378,069
20206741,541$602,501
20216371,359$674,292
20226911,417$516,739
20235551,272$965,548
20245631,224$1,037,748

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more626946$60
17110Destruction of skin growth, 1-14 growths108117$44
17000Destruction of precancer skin growth, 1 growth415550$32
11102Biopsy of related skin growth, first growth144164$21
17003Destruction of precancer skin growth, 2-14 growths2801,218$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa261,988$559,339
OtezlaApremilast461,386$220,702
Clobetasol PropionateClobetasol Propionate872,680$7,333
FluorouracilFluorouracil671,786$5,370
ImiquimodImiquimod2384,455$5,149

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$730ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carol H. Cooper, M.D.?

Tedicare shows public-source Medicare data for Carol H. Cooper, M.D. (NPI 1154346369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carol H. Cooper, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carol H. Cooper, M.D.?

Carol H. Cooper, M.D. is linked to KING'S DAUGHTERS MEDICAL SPECIALTIES, INC. (billing NPI 1265063580) in the available physician profile data.

Does Carol H. Cooper, M.D. have Open Payments data?

Carol H. Cooper, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.